| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.045 | 0.5 |